Lasting effects of early postnatal use of clomipramine on sleep-wakefulness cycle are ameliorated by ICV microinjection of Orexin-a (Hypocretin-1) and Orexin-b (Hypocretin-2)

Autor:	N. Rogava, M. Shavgulidze, N. Maglakelidze, N. Nachkebia, K. Bejanishvili, O. Mchedlidze, V. Tsomaia, S. Dzadzamia
Rok vydání:	2017
Předmět:	Clomipramine medicine.medical_specialty Endocrinology Sleep wakefulness business.industry Internal medicine Orexin a hypocretin 1 Medicine General Medicine business Microinjection Orexin medicine.drug
Zdroj:	Sleep Medicine. 40:e206
ISSN:	1389-9457
DOI:	10.1016/j.sleep.2017.11.602
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::852bf8e1b4d9e77f7522149dfc87538e https://doi.org/10.1016/j.sleep.2017.11.602 Zobrazit plný text záznamu Full Text from ScienceDirect